(NAS Colloquium) Genetic Engineering of Viruses and Viral Vectors (1996)

Chapter: Development of HIV vectors for anti-HIV gene therapy

Previous Chapter: Use of virion DNA as a cloning vector for the construction of mutant and recombinant herpesviruses
Suggested Citation: "Development of HIV vectors for anti-HIV gene therapy." National Academy of Sciences. 1996. (NAS Colloquium) Genetic Engineering of Viruses and Viral Vectors. Washington, DC: The National Academies Press. doi: 10.17226/5708.
Page 11395
Suggested Citation: "Development of HIV vectors for anti-HIV gene therapy." National Academy of Sciences. 1996. (NAS Colloquium) Genetic Engineering of Viruses and Viral Vectors. Washington, DC: The National Academies Press. doi: 10.17226/5708.
Page 11396
Suggested Citation: "Development of HIV vectors for anti-HIV gene therapy." National Academy of Sciences. 1996. (NAS Colloquium) Genetic Engineering of Viruses and Viral Vectors. Washington, DC: The National Academies Press. doi: 10.17226/5708.
Page 11397
Suggested Citation: "Development of HIV vectors for anti-HIV gene therapy." National Academy of Sciences. 1996. (NAS Colloquium) Genetic Engineering of Viruses and Viral Vectors. Washington, DC: The National Academies Press. doi: 10.17226/5708.
Page 11398
Suggested Citation: "Development of HIV vectors for anti-HIV gene therapy." National Academy of Sciences. 1996. (NAS Colloquium) Genetic Engineering of Viruses and Viral Vectors. Washington, DC: The National Academies Press. doi: 10.17226/5708.
Page 11399
Next Chapter: A stable human-derived packaging cell line for production of high titer retrovirus/vesicular stomatitis virus G pseudotypes
Subscribe to Email from the National Academies
Keep up with all of the activities, publications, and events by subscribing to free updates by email.